Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (503)	8/9/2002 10:21:53 AM
From: Jibacoa	Read Replies (2) of 544

ALKS Has continued its up-move after it announced yesterday that JNJ had obtained approval in Germany for the long acting form of Risperdal and also obtained same approval in U.K. today. The stock seems ready to close some of the July 1st down-gap that was triggered when the FDA rejected approval of the drug in the U.S.A.<g> siliconinvestor.com siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next